Drug
Standard Medication Therapy
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_3
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Not yet recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 32 (66.7%)
N/A1 (33.3%)
Trials by Status
not_yet_recruiting267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
Remote Ischemic Conditioning for the Treatment of Diabetic Kidney Disease
NCT06654921
not_yet_recruitingphase_3
Tibial Nerve Stimulation for Post-BPH Overactive Bladder
NCT06558539
unknownphase_3
Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage
NCT04657133
Clinical Trials (3)
Showing 3 of 3 trials
NCT06654921Not Applicable
Remote Ischemic Conditioning for the Treatment of Diabetic Kidney Disease
NCT06558539Phase 3
Tibial Nerve Stimulation for Post-BPH Overactive Bladder
NCT04657133Phase 3
Remote Ischemic Conditioning for the Treatment of Intracerebral Hemorrhage
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3